Manganese-enhanced MRI: Comparison of agents in the rat pancreas

Manganese-enhanced MRI: Comparison of agents in the rat pancreas

Mangafodipir was approved for use as an MRI contrast agent in the late 1990s for liver and pancreas imaging but it was removed from the European market for commercial reasons in 2012. Previously, preliminary work in mice and in diabetic patients showed that Mn2+ ions could be used as a contrast agen...

Full description

Bibliographic Details
Main Authors: Lucy E Kershaw, David ML Lilburn, Maurits A. Jansen, Andrew R Bond, Salamah M Alwahsh, Pilar Jimenez-Royo, Antonella Napolitano, Philip Murphy, Alexandra Roberts, Rob Janiczek, Shareen Forbes, Scott IK Semple
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Journal of Magnetic Resonance Open
Subjects:
Manganese
Diabetes
Pancreas
β-cells
Pancreatic islets
Online Access:http://www.sciencedirect.com/science/article/pii/S2666441020300029

Internet

http://www.sciencedirect.com/science/article/pii/S2666441020300029

Similar Items